Omnio AB

📍 Umeå, Sweden👥 12 employees💰 Last funded Jun 2024
Omnio AB is a biopharmaceutical company dedicated to revolutionizing the treatment of diabetic foot ulcers (DFUs) through the development of recombinant plasminogen therapeutics.
2
Total investors
0
Early stage
0
Mid stage
0
Late stage
Founded
Investor geography2 countries
Sweden
1
Netherlands
1
Frequently asked questions
Who invested in Omnio AB?
Omnio AB has 2 investors on record on gritt.io.
When did Omnio AB last raise funding?
The most recent investment in Omnio AB recorded on gritt.io was in June 2024.
What industry is Omnio AB in?
Omnio AB operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Omnio AB based?
Omnio AB is headquartered in Umeå, Sweden.